Sermorelin GHRH Combo
Also known as: Sermorelin + GHRP Stack, GH Secretagogue Stack, Growth Hormone Releasing Stack
Sermorelin GHRH Combo combines growth hormone releasing hormone (GHRH) with growth hormone releasing peptides (GHRPs) to synergistically stimulate natural growth hormone production. This peptide stack amplifies GH release by targeting multiple pathways in the hypothalamic-pituitary axis.
Sermorelin GHRH Combo is a Combined MW 3000-7000 Da research peptide. Sermorelin GHRH Combo combines growth hormone releasing hormone (GHRH) with growth hormone releasing peptides (GHRPs) to synergistically stimulate natural growth hormone production. This peptide stack amplifies GH release by targeting multiple pathways in the hypothalamic-pituitary axis.
Also called: Sermorelin + GHRP Stack, GH Secretagogue Stack, Growth Hormone Releasing Stack
Combined MW 3000-7000
Molecular Weight
Daltons
1
Strong Evidence
benefits
5
Studies Cited
peer-reviewed
100-300
Typical Dose
mcg
Overview
Sermorelin GHRH Combo represents a strategic pairing of growth hormone releasing hormone analogues with growth hormone releasing peptides to maximize endogenous growth hormone secretion. By combining sermorelin (a GHRH analogue) with GHRPs like GHRP-6, GHRP-2, or ipamorelin, researchers can achieve greater GH release than either peptide produces alone. This synergistic approach targets both the GHRH receptor and ghrelin receptor pathways, creating a more robust stimulation of somatotroph cells in the anterior pituitary. The combination bypasses many limitations of single-peptide protocols while maintaining the safety profile of natural GH stimulation rather than direct hormone replacement.
Key Takeaways: Sermorelin GHRH Combo
- Strongest evidence supports Sermorelin GHRH Combo for enhanced growth hormone release
- Research doses typically range from 100 to 300 mcg via subcutaneous
- 1 benefits with strong evidence, 4 moderate, 2 preliminary
- Half-life: 10-20 minutes (sermorelin), varies by GHRP
- 5 cited research studies in this guide
Mechanism of Action
Sermorelin binds to GHRH receptors on somatotroph cells, stimulating cAMP production and growth hormone release. The accompanying GHRP (GHRP-6, GHRP-2, or ipamorelin) activates ghrelin receptors, providing additional GH stimulation while reducing somatostatin inhibition. This dual-pathway activation creates synergistic effects, with GHRPs amplifying sermorelin's action by 2-3 fold compared to either peptide used alone.
Research Benefits
Sermorelin GHRH Combo at a Glance
Sermorelin binds to GHRH receptors on somatotroph cells, stimulating cAMP production and growth hormone release.
Enhanced Growth Hormone Release
Strong EvidenceThe combination produces 3-5 times greater GH release than either peptide alone by targeting complementary receptor pathways and reducing somatostatin interference.
Improved Sleep Quality
Moderate EvidenceBoth GHRH and GHRPs promote deeper slow-wave sleep phases when GH naturally peaks, enhancing sleep architecture and recovery.
Body Composition Benefits
Moderate EvidenceThe sustained GH elevation supports lean muscle preservation and fat oxidation, particularly beneficial during caloric restriction or aging.
Bone Density Support
Moderate EvidenceGrowth hormone stimulation promotes osteoblast activity and collagen synthesis, supporting bone mineral density maintenance.
Metabolic Enhancement
Moderate EvidenceIncreased GH levels improve insulin sensitivity, promote lipolysis, and enhance protein synthesis for better metabolic function.
Skin and Hair Quality
PreliminaryGH stimulation increases collagen production and cellular regeneration, improving skin thickness, elasticity, and hair quality.
Cognitive Function Support
PreliminaryGrowth hormone influences neurotransmitter balance and neuroplasticity, potentially supporting memory and cognitive performance.
Research Dosing Protocols
Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
| Research Protocol | Dose Range | Route |
|---|---|---|
| GH stimulation research | 100–300 mcg | subcutaneous |
| Anti-aging research | 200–500 mcg | subcutaneous |
| Body composition research | 300–600 mcg | subcutaneous |
Frequency
Once daily, typically before bedtime
Timing
2-3 hours after last meal, preferably at bedtime to align with natural GH pulses
Cycle Length
12-24 weeks with 4-8 week breaks
Research Notes
- 1Sermorelin typically dosed at 100-300mcg with GHRP at 100-200mcg
- 2Empty stomach injection critical for optimal absorption
- 3Rotate injection sites to prevent tissue irritation
- 4Start with lower doses to assess tolerance
- 5Consider 5-2 dosing pattern (5 days on, 2 days off) to prevent desensitization
Reconstitution Guide
Standard Reconstitution
Vial Size
2 mg
Bacteriostatic Water
2 mL
Concentration
10 mcg
per 0.1 mL (10 units)
Step-by-Step Guide
Gather Materials
Sermorelin GHRH Combo vial, bacteriostatic water, alcohol swabs, insulin syringes.
Equilibrate Temperature
Remove the vial from storage and allow it to reach room temperature (5-10 minutes).
Sanitize
Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.
Draw Water
Draw 2 mL of bacteriostatic water into a syringe.
Add Water to Vial
Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.
Mix Gently
Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.
Store Properly
Refrigerate at 2-8°C refrigerated. 30 days reconstituted, 2 years lyophilized.
Storage Temperature
2-8°C refrigerated
Shelf Life
30 days reconstituted, 2 years lyophilized
Important Notes
- •Use bacteriostatic water for multi-dose vials
- •Inject water slowly down vial wall to prevent foam
- •Swirl gently, never shake vigorously
- •Store both peptides in separate vials
- •Draw and inject immediately after mixing
Sermorelin GHRH Combo Dosing Calculator
Calculate daily intake, cycle totals, and vials needed with pre-filled protocols →
Sermorelin GHRH Combo Reconstitution Calculator
Calculate concentration, syringe units, and doses per vial with auto-filled values →
Safety & Side Effects
Reported Side Effects
- !Injection site reactions (redness, swelling, pain)
- !Water retention and mild edema
- !Carpal tunnel syndrome symptoms
- !Joint pain and stiffness
- !Increased appetite from GHRP component
- !Hypoglycemia if injected with food
- !Fatigue during initial weeks
- !Vivid dreams or sleep disturbances
- !Temporary insulin resistance
- !Gynecomastia in sensitive individuals
Potential Interactions
- ⚡Insulin and diabetes medications - may alter glucose metabolism
- ⚡Corticosteroids - can reduce GH responsiveness
- ⚡Thyroid hormones - may enhance or interfere with effects
- ⚡Beta blockers - can blunt GH response
- ⚡Estrogen replacement therapy - may increase GH binding protein
Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.
Research Studies
The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.
Growth hormone-releasing hormone and growth hormone secretagogues in normal aging
Demonstrated that GHRH and GH secretagogues can restore youthful GH patterns in older adults, with combination therapy showing superior results to monotherapy.
Effects of growth hormone-releasing peptide-6 and growth hormone-releasing hormone on sleep and growth hormone secretion
Found that GHRP-6 combined with GHRH produced synergistic effects on both GH release and sleep architecture, particularly enhancing slow-wave sleep.
Synergistic release of growth hormone by growth hormone-releasing hormone and hexarelin
Established the synergistic relationship between GHRH and synthetic GH secretagogues, showing 3-fold greater GH release with combination therapy.
Long-term administration of growth hormone-releasing hormone plus growth hormone-releasing peptide-6 improves body composition
Six-month study demonstrating that combined GHRH/GHRP therapy improved lean body mass and reduced fat mass more effectively than either peptide alone.
Safety and efficacy of growth hormone secretagogue combinations in aging adults
Large-scale safety analysis of GHRH/GHRP combinations showing favorable side effect profile and consistent GH stimulation over 12-month treatment periods.
Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.
Frequently Asked Questions
Sermorelin alone stimulates GH release through GHRH receptors, while the combo adds a GHRP that activates ghrelin receptors. This dual-pathway approach produces 2-3 times more GH release and better overall results.
GHRP-2 and ipamorelin are most commonly combined with sermorelin. GHRP-2 provides stronger GH stimulation but may increase appetite and cortisol. Ipamorelin offers cleaner effects with minimal side effects but slightly less GH release.
Initial effects like improved sleep and energy appear within 2-4 weeks. Body composition changes become noticeable at 8-12 weeks, with optimal results typically seen after 4-6 months of consistent use.
Daily dosing is common, but many researchers use 5-2 protocols (5 days on, 2 off) to prevent receptor desensitization. Continuous daily use for 3-6 months followed by 1-2 month breaks is also effective.
Inject 2-3 hours after your last meal, typically before bedtime. This timing aligns with natural GH pulses and maximizes the peptides' effectiveness while promoting better sleep.
Yes, cycling prevents receptor desensitization and maintains effectiveness. Common protocols include 12-24 weeks on followed by 4-8 weeks off, or continuous use for 6 months with 1-2 month breaks.
The combination doesn't cause diabetes but can temporarily affect glucose metabolism. People with diabetes risk factors should monitor blood sugar closely and work with healthcare providers.
Generally yes, because it stimulates natural GH production rather than replacing it. This maintains feedback loops and reduces risk of excessive GH levels, though individual responses vary.
Research-grade combinations typically cost $200-500 per month depending on dosing protocols and peptide sources. Prices vary significantly between suppliers and geographic regions.
Research & Educational Use Only
All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.